These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3827327)

  • 21. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
    Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ
    J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
    Montie JE
    J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combination (RaHPP) of radiotherapy, hyperthermia and chemotherapy (peplomycin and picibanil) for bladder cancer].
    Washida H; Tsugaya M; Hirao N; Hachisuka Y
    Hinyokika Kiyo; 1984 Sep; 30(9):1159-66. PubMed ID: 6084419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined chemotherapy and irradiation for transitional cell cancer of the bladder: a review.
    Beuzeboc P; Pontvert D; Pouillart P; Cosset JM
    J Infus Chemother; 1995; 5(4):218-20. PubMed ID: 8934733
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
    Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
    Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
    Freiha F; Reese J; Torti FM
    J Urol; 1996 Feb; 155(2):495-9; discussion 499-500. PubMed ID: 8558644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing innovative strategies for advanced transitional cell carcinoma of the bladder.
    Pollera CF; Nelli F
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):83-92. PubMed ID: 16375647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Our experience in treating patients with surface cancer of the bladder].
    Matveev BP; Figurin KM; Romanov VA; Cheban NL
    Urol Nefrol (Mosk); 1995; (5):35-8. PubMed ID: 8571484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined modality treatment with selective bladder conservation for invasive bladder cancer: long-term tolerance in the female patient.
    Kachnic LA; Shipley WU; Griffin PP; Zietman AL; Kaufman DS; Althausen AF; Heney NM
    Cancer J Sci Am; 1996; 2(2):79-84. PubMed ID: 9166504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bladder cancer associated with von Recklinghausen's disease: a case report].
    Yonemura S; Okuno T; Yamada Y; Uchida K; Arima K; Yanagawa M; Kawamura J
    Hinyokika Kiyo; 1997 Aug; 43(8):585-8. PubMed ID: 9310783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative tumor board: transitional cell carcinoma of the bladder.
    Feng AY; Hogan TF; Lamm DL; Yarnell E; Philhower M; Krise M; Lundy VJ; Block KI
    Integr Cancer Ther; 2005 Mar; 4(1):48-64. PubMed ID: 15835094
    [No Abstract]   [Full Text] [Related]  

  • 34. The optimal management of T1G3 bladder cancer.
    Emiliozzi P; Pansadoro A; Pansadoro V
    BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
    [No Abstract]   [Full Text] [Related]  

  • 35. Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
    Koukourakis MI; Tsolos C; Touloupidis S
    Urology; 2007 Feb; 69(2):245-50. PubMed ID: 17320657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bladder cancer.
    Gwynn ES; Clark PE
    Curr Opin Oncol; 2006 May; 18(3):277-83. PubMed ID: 16552241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Classification and treatment of bladder cancer].
    Orv Hetil; 1986 Mar; 127(11):651. PubMed ID: 3960518
    [No Abstract]   [Full Text] [Related]  

  • 38. [Complex treatment of bladder cancer with pre- and postoperative chemotherapy].
    Klimenko IA; Goĭkhberg MI; Zaparin VK; Iaremko VN; Sakalo VS
    Urol Nefrol (Mosk); 1987; (1):26-8. PubMed ID: 3564196
    [No Abstract]   [Full Text] [Related]  

  • 39. Surgery and intravesical chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Semin Urol; 1983 Feb; 1(1):23-33. PubMed ID: 6433424
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravesical therapy for superficial bladder cancer: slow but steady progress.
    Lamm DL
    J Clin Oncol; 2003 Dec; 21(23):4259-60. PubMed ID: 14581444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.